Skip to main content

$0.056 -0.002 (-3.45%)

High

$0.06

Low

$0.06

Trades

69

Turnover

$115,211

Volume

1,984,515
30 June 2023 at 3:59pm
Register to track PYC and receive email alerts.
Subject
PYC Ann: FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL

PYC Ann: Change of Director's Interest Notice

PYC Ann: PYC Investor Update Presentation

PYC Ann: Q2 Investor Call 16 June 2023

PYC Ann: Phelan-McDermid Syndrome & CNS platform presentation

PYC Ann: Notice of General Meeting/Proxy Form

PYC Ann: Appointment of Joint Company Secretary

PYC Ann: Ceasing to be a substantial holder

PYC Ann: Ceasing to be a substantial holder

PYC Ann: Cleansing Notice Under Section 708AA

PYC Ann: Application for quotation of securities - PYC

PYC Ann: Proposed issue of securities - PYC

PYC Ann: Placement Supporting Document

PYC Ann: Successful Completion of $30m Placement

PYC Ann: Trading Halt

PYC Ann: PYC Presenting at TIDES USA 2023

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Commencement of First Clinical Study in RP11

PYC Ann: PYC BIO 2023 Presentation

PYC Ann: Second Drug Program Progressing to Human Trials

PYC Ann: Cleansing Notice Under Section 708AA

PYC Ann: Application for quotation of securities - PYC

PYC Ann: FDA Clears PYC to Commence First Human Trials in RP11

PYC Ann: Trading Halt

PYC Ann: Half Yearly Report and Accounts

PYC Ann: PYC Investor Update Presentation

PYC Ann: Issue of Options

PYC Ann: Notification regarding unquoted securities - PYC

PYC Ann: Q1 Investor Call 17 February 2023

PYC Ann: PYC Corporate Presentation - February 2023

PYC Ann: VP-001 IND Lodgement

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Notification of cessation of securities - PYC

PYC Ann: PYC Increases Ownership of VP-001 Program

PYC Ann: Results of Annual General Meeting

PYC Ann: 2022 AGM Chairman's Address and CEO Presentation

PYC Ann: Annual General Meeting - Conference Call

PYC Ann: Successful Toxicology Studies Pave Way for Human Trials

PYC Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PYC Ann: Issue of Options

PYC Ann: Notification regarding unquoted securities - PYC

PYC Ann: Notice of Annual General Meeting/Proxy Form

PYC Ann: PYC Presenting on Drug Delivery Platform at OTS 2022 Meeting

PYC Ann: Central Nervous System Drug Program Added to PYC Pipeline

PYC Ann: Corporate Governance Statement and Appendix 4G

PYC Ann: Annual Report to shareholders

PYC Ann: Preliminary Final Report

PYC Ann: PYC Shareholder Update

PYC Ann: Change of Director's Interest Notice

PYC Ann: PYC Therapeutics Investor Call - 18 August 2022

Register to track PYC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
RAC
TLX